NUTEX Investments (BUD:NUTEX) Beneish M-Score: 0.00 (As of Jul. 03, 2026)

What is NUTEX Investments Beneish M-Score?

NUTEX Investments BUD:NUTEX -0.37% 50 Beneish M-Score is 0.00 as of Jul. 03, 2026. GuruFocus rates BUD:NUTEX with a GF Score™ of 50/100 and a GF Value™ of Ft13.80 (Fairly Valued). The stock has 3 warning signs investors should review. Among 909 Drug Manufacturers companies, NUTEX Investments ranks worse than 110010.89% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for NUTEX Investments's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of NUTEX Investments was 323.58. The lowest was -4.20. And the median was 14.50.

NUTEX Investments Beneish M-Score Related Terms

NUTEX Investments Beneish M-Score Historical Data

* Premium members only.

The historical data trend for NUTEX Investments's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NUTEX Investments Beneish M-Score Chart

NUTEX Investments Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Beneish M-Score

Get a 7-Day Free Trial

22.36

323.58

4.20

0.00

NUTEX Investments Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Beneish M-Score	Get a 7-Day Free Trial															4.20	0.00	0.00	0.00	0.00

BUD:NUTEX vs ZTS, UTHR, VTRS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NUTEX Investments's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NUTEX Investments Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NUTEX Investments's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where NUTEX Investments's Beneish M-Score falls into.

Save Embed

50GF Score

NUTEX Investments PLC BUD:NUTEX

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

NUTEX Investments Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of NUTEX Investments for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Dec25) TTM:

Last Year (Dec24) TTM:

Total Receivables was Ft178.64 Mil.
Revenue was Ft0.45 Mil.
Gross Profit was Ft0.45 Mil.
Total Current Assets was Ft5,555.06 Mil.
Total Assets was Ft5,555.28 Mil.
Property, Plant and Equipment(Net PPE) was Ft0.22 Mil.
Depreciation, Depletion and Amortization(DDA) was Ft0.32 Mil.
Selling, General, & Admin. Expense(SGA) was Ft108.89 Mil.
Total Current Liabilities was Ft35.72 Mil.
Long-Term Debt & Capital Lease Obligation was Ft0.00 Mil.
Net Income was Ft494.17 Mil.
Gross Profit was Ft0.00 Mil.
Cash Flow from Operations was Ft256.33 Mil.

Total Receivables was Ft224.08 Mil.
Revenue was Ft0.45 Mil.
Gross Profit was Ft0.45 Mil.
Total Current Assets was Ft4,998.23 Mil.
Total Assets was Ft4,998.36 Mil.
Property, Plant and Equipment(Net PPE) was Ft0.13 Mil.
Depreciation, Depletion and Amortization(DDA) was Ft0.10 Mil.
Selling, General, & Admin. Expense(SGA) was Ft97.12 Mil.
Total Current Liabilities was Ft42.42 Mil.
Long-Term Debt & Capital Lease Obligation was Ft0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(178.638 / 0.45)	/	(224.08 / 0.45)
	=	396.973333	/	497.955556
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.45 / 0.45)	/	(0.45 / 0.45)
	=	1	/	1
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (5555.057 + 0.223) / 5555.28)	/	(1 - (4998.229 + 0.131) / 4998.36)
	=	0	/	-0
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.45	/	0.45
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.095 / (0.095 + 0.131))	/	(0.315 / (0.315 + 0.223))
	=	0.420354	/	0.585502
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(108.89 / 0.45)	/	(97.119 / 0.45)
	=	241.977778	/	215.82
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 35.718) / 5555.28)	/	((0 + 42.421) / 4998.36)
	=	0.00643	/	0.008487
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(494.171 - 0	-	256.33)	/	5555.28
	=	0.042814

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of 0.00 mean?

NUTEX Investments (BUD:NUTEX) has a Beneish M-Score of 0.00 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on NUTEX Investments and its competitors. According to the industry distribution chart, NUTEX Investments ranks #999999 out of 909 companies in the Drug Manufacturers industry.

Is NUTEX Investments' Beneish M-Score too high?

NUTEX Investments' current Beneish M-Score is 0.00. Based on the distribution chart, NUTEX Investments ranks #999999 out of 909 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, NUTEX Investments has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does NUTEX Investments' Beneish M-Score compare to ZTS and UTHR?

According to the Drug Manufacturers industry distribution chart, NUTEX Investments ranks #999999 out of 909 companies for Beneish M-Score. This places NUTEX Investments in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Drug Manufacturers company?

A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on NUTEX Investments and its competitors. NUTEX Investments's current Beneish M-Score is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is NUTEX Investments stock overvalued right now?

Based on GuruFocus' analysis, NUTEX Investments (BUD:NUTEX) is currently considered Fairly Valued. The stock's GF Value™ is Ft13.80, compared to a current price of Ft13.40 — trading 2.9% below its estimated fair value. The current Beneish M-Score is 0.00. NUTEX Investments' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For NUTEX Investments (BUD:NUTEX), the current Beneish M-Score is 0.00 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NUTEX Investments (BUD:NUTEX) Overvalued in 2026?

Based on GuruFocus' analysis, NUTEX Investments stock appears to be undervalued. The current stock price of Ft13.40 is trading 2.9% below its estimated GF Value™ of Ft13.80. GuruFocus considers NUTEX Investments to be Fairly Valued.

Key valuation signals for BUD:NUTEX:

Beneish M-Score: 0.00
GF Value™: Ft13.80 vs. price of Ft13.40 (2.9% below fair value)
GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the BUD:NUTEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NUTEX Investments Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506 XPAR:IPN TSE:4507 TPE:6446

Address Telepes u. 53., Budapest, HUN, 1147

Website https://www.nutex.hu

NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.

50GF Score

Get the complete analysis for BUD:NUTEX

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Ft13.40

Price

Ft13.80

GF Value

View BUD:NUTEX Analysis

See Beneish M-Score data for all stocks →